| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cadherin binding | 5.30e-05 | 339 | 78 | 8 | GO:0045296 | |
| GeneOntologyMolecularFunction | eukaryotic initiation factor eIF2 binding | 8.99e-05 | 4 | 78 | 2 | GO:0071074 | |
| GeneOntologyMolecularFunction | phosphatidic acid transfer activity | 3.12e-04 | 7 | 78 | 2 | GO:1990050 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 5.35e-04 | 599 | 78 | 9 | GO:0050839 | |
| GeneOntologyBiologicalProcess | dense core granule docking | 1.38e-05 | 2 | 77 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | regulation of embryonic cell shape | 4.12e-05 | 3 | 77 | 2 | GO:0016476 | |
| GeneOntologyBiologicalProcess | dense core granule priming | 8.21e-05 | 4 | 77 | 2 | GO:0061789 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | 9.03e-05 | 493 | 77 | 9 | GO:0007018 | |
| GeneOntologyCellularComponent | cytoplasmic region | UNC13B ARFGEF2 CFAP43 CFAP61 SEPTIN7 DNAH8 UNC13A MADD HNRNPU | 7.73e-06 | 360 | 78 | 9 | GO:0099568 |
| GeneOntologyCellularComponent | cell cortex | 7.25e-05 | 371 | 78 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | axon | UNC13B TENM3 SCN1A SPTBN1 DNM3 DAG1 SPG11 SEPTIN7 UNC13A MADD CA2 ITPR2 | 1.09e-04 | 891 | 78 | 12 | GO:0030424 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.81e-04 | 317 | 78 | 7 | GO:0032838 | |
| GeneOntologyCellularComponent | proteasome core complex, alpha-subunit complex | 3.79e-04 | 8 | 78 | 2 | GO:0019773 | |
| GeneOntologyCellularComponent | axoneme | 1.07e-03 | 207 | 78 | 5 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.09e-03 | 208 | 78 | 5 | GO:0097014 | |
| HumanPheno | Absent sperm flagella | 1.81e-05 | 28 | 30 | 4 | HP:0032558 | |
| HumanPheno | Coiled sperm flagella | 3.14e-05 | 32 | 30 | 4 | HP:0032560 | |
| HumanPheno | Short sperm flagella | 3.55e-05 | 33 | 30 | 4 | HP:0032559 | |
| HumanPheno | Irregularly shaped sperm tail | 8.00e-05 | 15 | 30 | 3 | HP:0033393 | |
| HumanPheno | Abnormal sperm tail morphology | 1.03e-04 | 43 | 30 | 4 | HP:0012868 | |
| Domain | Unc-13 | 5.02e-05 | 3 | 77 | 2 | IPR027080 | |
| Domain | Actinin_actin-bd_CS | 1.12e-04 | 23 | 77 | 3 | IPR001589 | |
| Domain | Spectrin | 1.12e-04 | 23 | 77 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.12e-04 | 23 | 77 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.12e-04 | 23 | 77 | 3 | PS00019 | |
| Domain | Munc13_dom-2 | 1.66e-04 | 5 | 77 | 2 | IPR014772 | |
| Domain | Membr_traf_MHD | 1.66e-04 | 5 | 77 | 2 | PF10540 | |
| Domain | MHD2 | 1.66e-04 | 5 | 77 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 1.66e-04 | 5 | 77 | 2 | IPR019558 | |
| Domain | DUF1041 | 1.66e-04 | 5 | 77 | 2 | SM01145 | |
| Domain | Spectrin_repeat | 2.28e-04 | 29 | 77 | 3 | IPR002017 | |
| Domain | PRELI_MSF1 | 2.49e-04 | 6 | 77 | 2 | PS50904 | |
| Domain | PRELI | 2.49e-04 | 6 | 77 | 2 | PF04707 | |
| Domain | PRELI/MSF1_dom | 2.49e-04 | 6 | 77 | 2 | IPR006797 | |
| Domain | Spectrin/alpha-actinin | 3.07e-04 | 32 | 77 | 3 | IPR018159 | |
| Domain | SPEC | 3.07e-04 | 32 | 77 | 3 | SM00150 | |
| Domain | DUF1041 | 3.48e-04 | 7 | 77 | 2 | PF06292 | |
| Domain | Munc13_1 | 3.48e-04 | 7 | 77 | 2 | IPR014770 | |
| Domain | CAPS_dom | 3.48e-04 | 7 | 77 | 2 | IPR010439 | |
| Domain | MHD1 | 3.48e-04 | 7 | 77 | 2 | PS51258 | |
| Domain | Proteasome_suA-type | 4.62e-04 | 8 | 77 | 2 | IPR023332 | |
| Domain | Proteasome_asu_N | 4.62e-04 | 8 | 77 | 2 | IPR000426 | |
| Domain | Proteasome_A_N | 4.62e-04 | 8 | 77 | 2 | SM00948 | |
| Domain | Proteasome_A_N | 4.62e-04 | 8 | 77 | 2 | PF10584 | |
| Domain | PROTEASOME_ALPHA_2 | 4.62e-04 | 8 | 77 | 2 | PS51475 | |
| Domain | PROTEASOME_ALPHA_1 | 4.62e-04 | 8 | 77 | 2 | PS00388 | |
| Domain | C1_1 | 1.68e-03 | 57 | 77 | 3 | PF00130 | |
| Domain | Diacylglycerol_kinase_cat_dom | 1.70e-03 | 15 | 77 | 2 | IPR001206 | |
| Domain | DAGK_cat | 1.70e-03 | 15 | 77 | 2 | PF00781 | |
| Domain | DAGK | 1.70e-03 | 15 | 77 | 2 | PS50146 | |
| Domain | NAD/diacylglycerol_kinase | 2.19e-03 | 17 | 77 | 2 | IPR016064 | |
| Domain | ZF_DAG_PE_1 | 2.34e-03 | 64 | 77 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 2.34e-03 | 64 | 77 | 3 | PS50081 | |
| Domain | C1 | 2.45e-03 | 65 | 77 | 3 | SM00109 | |
| Domain | CH | 2.45e-03 | 65 | 77 | 3 | SM00033 | |
| Domain | PE/DAG-bd | 2.56e-03 | 66 | 77 | 3 | IPR002219 | |
| Domain | Proteasome | 2.74e-03 | 19 | 77 | 2 | PF00227 | |
| Domain | Proteasome_sua/b | 2.74e-03 | 19 | 77 | 2 | IPR001353 | |
| Domain | CH | 3.02e-03 | 70 | 77 | 3 | PF00307 | |
| Domain | - | 3.15e-03 | 71 | 77 | 3 | 1.10.418.10 | |
| Domain | CH | 3.41e-03 | 73 | 77 | 3 | PS50021 | |
| Domain | CH-domain | 3.68e-03 | 75 | 77 | 3 | IPR001715 | |
| Pubmed | CMBL RALGAPA1 SND1 BCLAF1 SPTBN1 EIF5 DVL2 OSBPL8 MACF1 NCK1 PEAK1 SEPTIN7 HNRNPU ANKS1A | 5.69e-10 | 708 | 78 | 14 | 39231216 | |
| Pubmed | RBSN MIA3 BCLAF1 SCN1A DOCK9 SPTBN1 DVL2 OSBPL8 DAG1 MACF1 PEAK1 SEPTIN7 UNC13A YARS1 MADD HNRNPU | 4.03e-09 | 1139 | 78 | 16 | 36417873 | |
| Pubmed | RALGAPA1 SND1 BCLAF1 SPTBN1 OSBPL8 ARFGEF2 MACF1 DGKZ PEAK1 SEPTIN7 NDUFB5 UNC13A YARS1 MADD CA2 HNRNPU ITPR2 | 1.47e-08 | 1431 | 78 | 17 | 37142655 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | TENM3 SND1 DOCK9 SPTBN1 EIF5 LRATD2 DAG1 MACF1 NCK1 PEAK1 SEPTIN7 | 5.50e-08 | 565 | 78 | 11 | 25468996 |
| Pubmed | 1.20e-07 | 360 | 78 | 9 | 33111431 | ||
| Pubmed | RALGAPA1 KRT17 BCLAF1 PSMA2 SPTBN1 MACF1 CHD1L SEPTIN7 MADD HNRNPU | 3.54e-07 | 538 | 78 | 10 | 28524877 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 FSIP2 RBSN SPTBN1 SYNE2 EIF5 OSBPL8 MACF1 PEAK1 MAP3K3 MADD ANKS1A | 4.77e-07 | 861 | 78 | 12 | 36931259 |
| Pubmed | MIA3 BCLAF1 SPTBN1 SYNE2 DVL2 DNM3 MACF1 DGKZ SEPTIN7 UNC13A HNRNPU ANKS1A | 1.54e-06 | 963 | 78 | 12 | 28671696 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.79e-06 | 498 | 78 | 9 | 36634849 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MIA3 BCLAF1 PSMA2 SPTBN1 EIF5 DNM3 MACF1 DGKZ SEPTIN7 NDUFB5 HNRNPU | 2.95e-06 | 847 | 78 | 11 | 35235311 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KRT17 DCPS SND1 PSMA2 SPTBN1 EIF5 DVL2 ARFGEF2 MACF1 SEPTIN7 USP19 YARS1 HNRNPU ANKS1A | 3.94e-06 | 1455 | 78 | 14 | 22863883 |
| Pubmed | 4.15e-06 | 187 | 78 | 6 | 26460568 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 12070347 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 12871971 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 17561838 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 23070049 | ||
| Pubmed | Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming. | 4.97e-06 | 2 | 78 | 2 | 28489077 | |
| Pubmed | Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. | 4.97e-06 | 2 | 78 | 2 | 10440375 | |
| Pubmed | Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin. | 4.97e-06 | 2 | 78 | 2 | 22066784 | |
| Pubmed | Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses. | 4.97e-06 | 2 | 78 | 2 | 32187536 | |
| Pubmed | Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18. | 4.97e-06 | 2 | 78 | 2 | 28772123 | |
| Pubmed | Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. | 4.97e-06 | 2 | 78 | 2 | 17267576 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 22814762 | ||
| Pubmed | Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release. | 4.97e-06 | 2 | 78 | 2 | 28426965 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 35613050 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 23770256 | ||
| Pubmed | Membrane bridging by Munc13-1 is crucial for neurotransmitter release. | 4.97e-06 | 2 | 78 | 2 | 30816091 | |
| Pubmed | A common molecular basis for membrane docking and functional priming of synaptic vesicles. | 4.97e-06 | 2 | 78 | 2 | 19558619 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 18701688 | ||
| Pubmed | Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses. | 4.97e-06 | 2 | 78 | 2 | 31851910 | |
| Pubmed | Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. | 4.97e-06 | 2 | 78 | 2 | 11832228 | |
| Pubmed | Munc13 controls the location and efficiency of dense-core vesicle release in neurons. | 4.97e-06 | 2 | 78 | 2 | 23229896 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 11792326 | ||
| Pubmed | UNC13B SUPT20H SPTBN1 OSBPL8 DNM3 ARFGEF2 MACF1 NCK1 SEPTIN7 SKIL NDUFB5 YARS1 MADD | 5.32e-06 | 1285 | 78 | 13 | 35914814 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DCPS SND1 BCLAF1 SPTBN1 SYNE2 EIF5 DVL2 DAG1 FAM114A2 SIN3A SEPTIN7 USP19 HNRNPU | 1.03e-05 | 1367 | 78 | 13 | 32687490 |
| Pubmed | Munc13- and SNAP25-dependent molecular bridges play a key role in synaptic vesicle priming. | 1.49e-05 | 3 | 78 | 2 | 37343100 | |
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 23658173 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 17639022 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 26304632 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 33105896 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 22966208 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 15988013 | ||
| Pubmed | 1.77e-05 | 504 | 78 | 8 | 34432599 | ||
| Pubmed | KRT17 SND1 BCLAF1 PSMA2 SPTBN1 SYNE2 PKHD1 MACF1 FAM114A2 SPG11 DNAH8 PSMA8 HNRNPU | 1.81e-05 | 1442 | 78 | 13 | 35575683 | |
| Pubmed | 2.16e-05 | 374 | 78 | 7 | 23824909 | ||
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 2.19e-05 | 375 | 78 | 7 | 32788342 | |
| Pubmed | RALGAPA1 AIFM2 MIA3 SND1 BCLAF1 SPTBN1 SYNE2 OSBPL8 MACF1 SPG11 PEAK1 NDUFB5 ITPR2 | 2.50e-05 | 1487 | 78 | 13 | 33957083 | |
| Pubmed | 2.76e-05 | 156 | 78 | 5 | 22952844 | ||
| Pubmed | Transient, phorbol ester-induced DOC2-Munc13 interactions in vivo. | 2.97e-05 | 4 | 78 | 2 | 10488064 | |
| Pubmed | Fbxo45, a novel ubiquitin ligase, regulates synaptic activity. | 2.97e-05 | 4 | 78 | 2 | 19996097 | |
| Pubmed | Munc13-1-mediated vesicle priming contributes to secretory amyloid precursor protein processing. | 2.97e-05 | 4 | 78 | 2 | 15123597 | |
| Pubmed | ELKS1 localizes the synaptic vesicle priming protein bMunc13-2 to a specific subset of active zones. | 2.97e-05 | 4 | 78 | 2 | 28264913 | |
| Pubmed | 3.69e-05 | 407 | 78 | 7 | 12693553 | ||
| Pubmed | 4.14e-05 | 568 | 78 | 8 | 37774976 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SND1 BCLAF1 ZNF280C EIF5 DVL2 MACF1 FAM114A2 SIN3A HNRNPU ANKS1A | 4.49e-05 | 934 | 78 | 10 | 33916271 |
| Pubmed | An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury. | 4.94e-05 | 5 | 78 | 2 | 34706221 | |
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 9988677 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 32755572 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 22248876 | ||
| Pubmed | Disentangling the Roles of RIM and Munc13 in Synaptic Vesicle Localization and Neurotransmission. | 4.94e-05 | 5 | 78 | 2 | 33139401 | |
| Pubmed | Identification of a Munc13-sensitive step in chromaffin cell large dense-core vesicle exocytosis. | 4.94e-05 | 5 | 78 | 2 | 26575293 | |
| Pubmed | Genome-wide association study of smoking behaviours among Bangladeshi adults. | 6.18e-05 | 34 | 78 | 3 | 24665060 | |
| Pubmed | 6.74e-05 | 35 | 78 | 3 | 24515614 | ||
| Pubmed | Munc13-1 and Munc18-1 together prevent NSF-dependent de-priming of synaptic vesicles. | 7.40e-05 | 6 | 78 | 2 | 28635948 | |
| Pubmed | 7.40e-05 | 6 | 78 | 2 | 17803907 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | MIA3 BCLAF1 PSMA2 SPTBN1 ZNF280C OSBPL8 DAG1 SIN3A NDUFB5 CA2 HNRNPU | 7.55e-05 | 1203 | 78 | 11 | 29180619 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 8.14e-05 | 807 | 78 | 9 | 30575818 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 8.37e-05 | 197 | 78 | 5 | 20811636 | |
| Pubmed | 8.82e-05 | 322 | 78 | 6 | 26514267 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 11724572 | ||
| Pubmed | A role for SKIP in EBNA2 activation of CBF1-repressed promoters. | 1.04e-04 | 7 | 78 | 2 | 10644367 | |
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 11306568 | ||
| Pubmed | A genome-wide association meta-analysis of preschool internalizing problems. | 1.04e-04 | 7 | 78 | 2 | 24839885 | |
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 18212064 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 15893389 | ||
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 1.04e-04 | 7 | 78 | 2 | 36398873 | |
| Pubmed | 1.29e-04 | 497 | 78 | 7 | 23414517 | ||
| Pubmed | 1.38e-04 | 8 | 78 | 2 | 10049357 | ||
| Pubmed | Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells. | 1.38e-04 | 8 | 78 | 2 | 25609709 | |
| Pubmed | 1.38e-04 | 8 | 78 | 2 | 31884020 | ||
| Pubmed | 1.56e-04 | 225 | 78 | 5 | 12168954 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.74e-04 | 123 | 78 | 4 | 26912792 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 1.76e-04 | 231 | 78 | 5 | 36597993 | |
| Pubmed | RNF12 catalyzes BRF1 ubiquitination and regulates RNA polymerase III-dependent transcription. | 1.97e-04 | 50 | 78 | 3 | 30413534 | |
| Pubmed | 2.02e-04 | 128 | 78 | 4 | 30995482 | ||
| Pubmed | 2.21e-04 | 10 | 78 | 2 | 33773096 | ||
| Pubmed | SNARE protein recycling by αSNAP and βSNAP supports synaptic vesicle priming. | 2.21e-04 | 10 | 78 | 2 | 21040848 | |
| Pubmed | 2.40e-04 | 733 | 78 | 8 | 34672954 | ||
| Pubmed | 2.45e-04 | 248 | 78 | 5 | 32963011 | ||
| Pubmed | 2.59e-04 | 251 | 78 | 5 | 27507650 | ||
| Pubmed | The morphological and molecular nature of synaptic vesicle priming at presynaptic active zones. | 2.70e-04 | 11 | 78 | 2 | 25374362 | |
| Pubmed | Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors. | 2.70e-04 | 11 | 78 | 2 | 39256359 | |
| Pubmed | Molecular and functional architecture of striatal dopamine release sites. | 2.70e-04 | 11 | 78 | 2 | 34767769 | |
| Pubmed | 3.09e-04 | 143 | 78 | 4 | 32560809 | ||
| Pubmed | Many sequence variants affecting diversity of adult human height. | 3.09e-04 | 143 | 78 | 4 | 18391951 | |
| Pubmed | 3.20e-04 | 263 | 78 | 5 | 34702444 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SND1 BCLAF1 SPTBN1 ZNF280C EIF5 PEAK1 SEPTIN7 USP19 YARS1 CA2 HNRNPU | 3.29e-04 | 1425 | 78 | 11 | 30948266 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 3.36e-04 | 582 | 78 | 7 | 20467437 | |
| Pubmed | 3.38e-04 | 266 | 78 | 5 | 19380743 | ||
| Pubmed | 3.54e-04 | 777 | 78 | 8 | 35844135 | ||
| Interaction | KCNA3 interactions | CMBL RALGAPA1 SND1 BCLAF1 SPTBN1 EIF5 DVL2 PKHD1 OSBPL8 MACF1 NCK1 PEAK1 SEPTIN7 HNRNPU ANKS1A | 8.75e-07 | 871 | 77 | 15 | int:KCNA3 |
| Interaction | LAMP2 interactions | RALGAPA1 RBSN SPTBN1 SYNE2 OSBPL8 ARFGEF2 SPG11 CHD1L PEAK1 SEPTIN7 USP19 HNRNPU | 3.18e-06 | 609 | 77 | 12 | int:LAMP2 |
| Interaction | KCTD13 interactions | RALGAPA1 SND1 BCLAF1 SPTBN1 OSBPL8 ARFGEF2 MACF1 DGKZ PEAK1 SEPTIN7 NDUFB5 UNC13A YARS1 MADD CA2 HNRNPU ITPR2 | 1.59e-05 | 1394 | 77 | 17 | int:KCTD13 |
| Interaction | UBASH3B interactions | 3.05e-05 | 157 | 77 | 6 | int:UBASH3B | |
| Interaction | GAN interactions | 5.15e-05 | 253 | 77 | 7 | int:GAN | |
| Cytoband | 2q24.3 | 3.37e-04 | 16 | 78 | 2 | 2q24.3 | |
| GeneFamily | UNC13 homologs | 4.85e-05 | 4 | 52 | 2 | 836 | |
| GeneFamily | SEC14 family|PRELI domain containing | 1.21e-04 | 6 | 52 | 2 | 1295 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 2.53e-05 | 98 | 75 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 5.83e-08 | 198 | 78 | 7 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.75e-07 | 166 | 78 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.40e-07 | 183 | 78 | 6 | 58847e8f3a7ce3e33adba9477bcd55e769a64a90 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.53e-05 | 178 | 78 | 5 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 181 | 78 | 5 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.80e-05 | 184 | 78 | 5 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.84e-05 | 185 | 78 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.84e-05 | 185 | 78 | 5 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.84e-05 | 185 | 78 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.94e-05 | 187 | 78 | 5 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 1.99e-05 | 188 | 78 | 5 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.99e-05 | 188 | 78 | 5 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-05 | 188 | 78 | 5 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.04e-05 | 189 | 78 | 5 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.04e-05 | 189 | 78 | 5 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 2.04e-05 | 189 | 78 | 5 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 2.04e-05 | 189 | 78 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 191 | 78 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC3|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.15e-05 | 191 | 78 | 5 | 6eaf72b41084404bee0db04e4605db745a74995f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-05 | 193 | 78 | 5 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.32e-05 | 194 | 78 | 5 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.37e-05 | 195 | 78 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.37e-05 | 195 | 78 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.37e-05 | 195 | 78 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | (05)_Ciliated|World / shred by cell type and Timepoint | 2.49e-05 | 197 | 78 | 5 | fee3cd16af8eea697cd64e8f64af505aaa2ac4b0 | |
| ToppCell | systemic_lupus_erythematosus-treated|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.55e-05 | 198 | 78 | 5 | 8165ff735095c52994fb5057d89be93cc378b7da | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.55e-05 | 198 | 78 | 5 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-05 | 199 | 78 | 5 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-05 | 199 | 78 | 5 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | af6a551f83808c1c839df7ba7b1702ca28ea6e1b | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | 73ac1cf40ddd764be1100cbfaaa29563665457d8 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.68e-05 | 200 | 78 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Ciliated_cells-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.36e-04 | 149 | 78 | 4 | 6399c5a2f06d79f020dece252526f1c0c110d569 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.59e-04 | 155 | 78 | 4 | d76a0f99ec35560d18820f9c92b69364ef2250e3 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.62e-04 | 156 | 78 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.88e-04 | 162 | 78 | 4 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.97e-04 | 164 | 78 | 4 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | Mild-MAIT|World / Disease group and Cell class | 1.97e-04 | 164 | 78 | 4 | 21dc02997dfae73cf70ce291661928526605dba1 | |
| ToppCell | COVID-19_Mild-PLT_0|COVID-19_Mild / Disease Group and Platelet Clusters | 2.01e-04 | 165 | 78 | 4 | 083a14d3b0162cee4e79f7398b8fb739582b39ff | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.16e-04 | 168 | 78 | 4 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-04 | 169 | 78 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | Ciliated_cells-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.26e-04 | 170 | 78 | 4 | 3d3a03979014df3a05c49be18010c6b94d786707 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.31e-04 | 171 | 78 | 4 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.31e-04 | 171 | 78 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.41e-04 | 173 | 78 | 4 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 173 | 78 | 4 | 2226505610af1becc253d0a5550627144ef0ed6b | |
| ToppCell | facs-Heart-RV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 176 | 78 | 4 | fb3d03f64592e1df1d9785d9f2e70938d7ff9ce8 | |
| ToppCell | facs-Heart-RV-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 176 | 78 | 4 | 3270a36fc91a5583646ffeb70bfcbc5af7292aac | |
| ToppCell | facs-Heart-RV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 176 | 78 | 4 | 99410c121f55adbc7fcc013c8fa8905a45dba76b | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.63e-04 | 177 | 78 | 4 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.69e-04 | 178 | 78 | 4 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.69e-04 | 178 | 78 | 4 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 178 | 78 | 4 | 6178706db4a855d72abc156537604d575624df56 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.69e-04 | 178 | 78 | 4 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 178 | 78 | 4 | f02076ece0fa899e620971c887ad4da7f48684ed | |
| ToppCell | normal-na-Lymphocytic_NK-T_mait-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.81e-04 | 180 | 78 | 4 | e66a8a61b3576ac37de7c559d16d4ed4f7a2fc78 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-04 | 180 | 78 | 4 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.87e-04 | 181 | 78 | 4 | 493a0222923ea04dadf17927c208671a046cd6df | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.87e-04 | 181 | 78 | 4 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.93e-04 | 182 | 78 | 4 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.93e-04 | 182 | 78 | 4 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 182 | 78 | 4 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 184 | 78 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 184 | 78 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 184 | 78 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.11e-04 | 185 | 78 | 4 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 3.18e-04 | 186 | 78 | 4 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.18e-04 | 186 | 78 | 4 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass | 3.24e-04 | 187 | 78 | 4 | 3cea677279e71fdb9879530dea10a5e6393beacd | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 3.24e-04 | 187 | 78 | 4 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.24e-04 | 187 | 78 | 4 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.31e-04 | 188 | 78 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 3.31e-04 | 188 | 78 | 4 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 3.31e-04 | 188 | 78 | 4 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | ILEUM-inflamed-(1)_Cytotoxic_CD8_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.31e-04 | 188 | 78 | 4 | d26894d1066a70e4b32ae41fff1c4718f2591ba9 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.38e-04 | 189 | 78 | 4 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 3.38e-04 | 189 | 78 | 4 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-04 | 189 | 78 | 4 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-04 | 189 | 78 | 4 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.38e-04 | 189 | 78 | 4 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.44e-04 | 190 | 78 | 4 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 191 | 78 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.51e-04 | 191 | 78 | 4 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.51e-04 | 191 | 78 | 4 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 191 | 78 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.51e-04 | 191 | 78 | 4 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.58e-04 | 192 | 78 | 4 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.58e-04 | 192 | 78 | 4 | 63d1b3efe93e5ff939278ebe40bacb38218ea09b | |
| ToppCell | PBMC-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 3.58e-04 | 192 | 78 | 4 | 41a7201febb7d88a39e4ee64df04cce18c691df8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.58e-04 | 192 | 78 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.58e-04 | 192 | 78 | 4 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.47e-05 | 50 | 43 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | estradiol, USP; Down 200; 0.1uM; HL60; HT_HG-U133A | 4.70e-06 | 197 | 77 | 7 | 2668_DN | |
| Disease | Congenital muscular dystrophy (disorder) | 9.50e-05 | 6 | 75 | 2 | C0699743 | |
| Disease | plasma renin activity measurement | 2.27e-04 | 9 | 75 | 2 | EFO_0006828 | |
| Disease | coffee consumption measurement, insomnia | 2.83e-04 | 10 | 75 | 2 | EFO_0004698, EFO_0006781 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 5.05e-04 | 144 | 75 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | platelet component distribution width | 6.60e-04 | 755 | 75 | 8 | EFO_0007984 | |
| Disease | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis | 7.64e-04 | 70 | 75 | 3 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0001060, EFO_0002609, EFO_0003898, EFO_0005140, EFO_0006812, MONDO_0005147, MONDO_0007915, MONDO_0015517 | |
| Disease | Child Behaviour Checklist assessment | 9.50e-04 | 18 | 75 | 2 | EFO_0005661 | |
| Disease | Intellectual Disability | 9.75e-04 | 447 | 75 | 6 | C3714756 | |
| Disease | Autism Spectrum Disorders | 1.34e-03 | 85 | 75 | 3 | C1510586 | |
| Disease | HDL cholesterol change measurement | 1.70e-03 | 24 | 75 | 2 | EFO_0007805 | |
| Disease | Squamous cell carcinoma of esophagus | 1.85e-03 | 95 | 75 | 3 | C0279626 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.32e-03 | 103 | 75 | 3 | EFO_0008595, EFO_0020944 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HISVEIKGEEKVAPY | 801 | Q9UPW8 | |
| ISVYDKESPQVVHKA | 456 | Q8NDM7 | |
| AKHVVLSTDEIVPYD | 751 | Q8NHU2 | |
| EEEPVITASCLHKEY | 1191 | Q8WWZ4 | |
| LDPTVEYVKFSKERH | 111 | O75815 | |
| EELEKVFQKTHYPDV | 166 | O95076 | |
| IPSAETYFHEEKIVV | 46 | H3BNL8 | |
| IVFYPATSKKEDAEH | 1566 | Q9Y6D5 | |
| TSTVEKIKIYTLEEH | 371 | Q8WYK0 | |
| DHIDKKYFPLTASEV | 421 | Q92625 | |
| EVKNKHPVEVVYLSE | 236 | Q7L7V1 | |
| DVKTTVVYPATEKHL | 126 | Q96C86 | |
| VGETKVIYHLDEEET | 11 | O14641 | |
| IDEKEHTPDIVKLYE | 266 | Q9H1K0 | |
| EIPTKITIHEYDSIT | 806 | Q14571 | |
| AFDVVVEVTEEHKPS | 2046 | Q14517 | |
| VPYHEIKSDRKEADI | 206 | Q9Y5R2 | |
| EFVPEIKEVVSHKYK | 1596 | Q8WXG6 | |
| ELVEHYKKAPIFTSE | 351 | P16333 | |
| DDPHKEEEIRKYSAI | 241 | Q13506 | |
| PEKSSEDDVYLHTVI | 741 | Q14118 | |
| KEEKNLVTEPTHYFI | 6776 | Q5CZC0 | |
| SIEHEVEAYKNFKPE | 306 | Q9UQ16 | |
| ISHTYEEIETESKVP | 661 | Q9H792 | |
| TEEEAIKYVTVDPTK | 696 | P51160 | |
| EPEENSKISHKTYLV | 491 | Q6P3R8 | |
| PVTDYEVLHKTRKEL | 1261 | Q96JB1 | |
| TEKIPVRHLYTKDID | 341 | Q00839 | |
| SAKIIDLYHEKTIPE | 61 | Q6ZU52 | |
| DLYHEKTIPEKVIES | 66 | Q6ZU52 | |
| EKLTHLSYKEVPTAD | 6 | Q96KN1 | |
| HTPEKDKVVSAFYTI | 266 | Q8NGX2 | |
| VDKDVFSVETPKKEH | 2151 | Q9UPN3 | |
| AKVVLTDPEAAKYVH | 331 | P04062 | |
| VEPLKETTYTEQSHE | 371 | Q9BZF1 | |
| FTVRKVHYDPEKDVH | 191 | Q8WXB1 | |
| IEVVYSKAASVPKVE | 401 | P55010 | |
| EDAHLTQYKKEPVTT | 391 | Q04695 | |
| DKLPVHVYEVDEEVD | 146 | Q9BZ29 | |
| YVVERPSTTKDKHKE | 466 | Q9NYF8 | |
| VATELPKKTEVVIYH | 266 | Q86WJ1 | |
| TKYVVHVKSLETEEE | 156 | Q5VWK5 | |
| FVETYTVEEVKVHPR | 486 | Q49MI3 | |
| EVTVETDKKTHYGLL | 226 | Q9NRY5 | |
| YTDEPVSKILSHVEE | 396 | Q13574 | |
| SRPVKYEDVEHKVTT | 61 | Q99759 | |
| TPRVHSIYKVEEVVK | 176 | Q9BQQ7 | |
| ITVEKHPDADSLYVE | 376 | P54577 | |
| TYVQEHSVVDPVEKT | 76 | Q9Y3B1 | |
| YDHPEIAVTVKTKEE | 796 | Q4G0N8 | |
| VPTVKKEHLDDYGEA | 46 | P12757 | |
| AEEVKDKVPSLTTYE | 2786 | Q8WXH0 | |
| HEYTKEELQVPTDET | 106 | Q5JRA6 | |
| IKTEYPEKEVTLIHS | 161 | Q9BRQ8 | |
| TYIREHSVVDPVEKK | 76 | Q96N28 | |
| ESVHLETYPKERATE | 526 | Q96ST3 | |
| EKVESPAKIHVFYID | 751 | Q7KZF4 | |
| SSYEPHEAEVLTVKE | 2901 | P08F94 | |
| YDRVTKPIVEKHEQE | 1986 | P35498 | |
| KIHRAEVTEEFKDPS | 151 | Q16533 | |
| ISVDHPDEKSIITYV | 256 | Q01082 | |
| VDIDTHTAKYDPSLK | 31 | P00918 | |
| QVEHIKAYVTKSPVD | 26 | Q96DG6 | |
| EKHEIIHSEEEPSEY | 106 | P17032 | |
| DEYDVHENVPKVKES | 666 | Q96JI7 | |
| YHEVTTVKKEEVIHG | 1156 | A4UGR9 | |
| EKGPDSVVVHVYVKE | 291 | O94966 | |
| PHYVVIKKDAETNEA | 276 | Q6GYQ0 | |
| QEHKIKIYEFPETDD | 216 | Q16181 | |
| SKPESKEEHAIYTAD | 301 | Q9BSI4 | |
| AIPSEVDVEKYAKVE | 301 | Q8NEM7 | |
| ENSEFVAYVKKEIPH | 251 | Q8IZ13 | |
| HTEYKELTAEPTIVA | 76 | Q9BU02 | |
| YETIDKELIDHSPKA | 171 | O43674 | |
| LYDERSVHKVEPITK | 56 | P25787 | |
| NPASKIHDVKDYITD | 2391 | Q9P273 | |
| ISVEIKGEEKVAPYH | 726 | O14795 | |
| KIVIHPKYQDTTADV | 101 | Q7RTY5 | |
| RHEGVTEKEPKTYTT | 301 | Q8ND82 | |
| YVPVLDKHVVSKVFD | 876 | Q502W6 | |
| SHKLTVEDPVTVEYI | 101 | Q8TAA3 |